Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER
Acta Pharmaceutica Sinica B
;
(6): 442-455, 2021.
Artigo
em Inglês
| WPRIM
| ID: wpr-881146
ABSTRACT
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that norlichexanthone (NOR), a natural product, is a ligand of estrogen receptor-alpha (ER
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Inglês
Revista:
Acta Pharmaceutica Sinica B
Ano de publicação:
2021
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS